In the past twelve months, regenerative medicine investments gained momentum, as new and promising clinical data got released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.
Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).
Mesenchymal Stem Cell Industry News Round Up | July 2015
The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.
While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for July 2015.
July is National Cord Blood Awareness Month
July is National Cord Blood Awareness Month. It is a time during which the importance of cord blood and tissue stem cells is celebrated. Importantly, hematopoietic stem cells (HSCs) from cord blood can now be used to treat more than 80 diseases and conditions. Mesenchymal stem cells present in cord tissue are also being explored in a wide range of clinical trials.
Cord Blood Awareness
There are three primary categories of people who need to increase their awareness about the importance of cord blood stem cells. These categories include:
- Expectant (pregnant) parents
- Extended support networks for parents, including brothers, sisters, grandparents, aunts, uncles and friends
- Medical practitioners, including nurses and Ob/Gyns
[ALLIANCE] Sistemic and RoosterBio Developing Regenerative Technologies Involving miRNA and Mesenchymal Stem/Stromal Cells
Short Summary: RoosterBio, Inc. and Sistemic have entered into an agreement to synergistically develop microRNA (miRNA)-based cell characterization technologies that will create more precise and relevant characterization panels for human mesenchymal stem cell (hMSC) products and in process cell banks.
[Read more…]
Mesenchymal Stem Cell Industry News Round Up | June 2015
The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.
While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for June 2015.
